1. Home
  2. HROW vs LKFN Comparison

HROW vs LKFN Comparison

Compare HROW & LKFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HROW
  • LKFN
  • Stock Information
  • Founded
  • HROW 1998
  • LKFN 1872
  • Country
  • HROW United States
  • LKFN United States
  • Employees
  • HROW N/A
  • LKFN N/A
  • Industry
  • HROW Biotechnology: Pharmaceutical Preparations
  • LKFN Major Banks
  • Sector
  • HROW Health Care
  • LKFN Finance
  • Exchange
  • HROW Nasdaq
  • LKFN Nasdaq
  • Market Cap
  • HROW 1.4B
  • LKFN 1.7B
  • IPO Year
  • HROW N/A
  • LKFN 1997
  • Fundamental
  • Price
  • HROW $33.71
  • LKFN $57.86
  • Analyst Decision
  • HROW Strong Buy
  • LKFN Buy
  • Analyst Count
  • HROW 7
  • LKFN 3
  • Target Price
  • HROW $68.50
  • LKFN $67.00
  • AVG Volume (30 Days)
  • HROW 558.8K
  • LKFN 109.1K
  • Earning Date
  • HROW 11-10-2025
  • LKFN 10-27-2025
  • Dividend Yield
  • HROW N/A
  • LKFN 3.48%
  • EPS Growth
  • HROW N/A
  • LKFN N/A
  • EPS
  • HROW N/A
  • LKFN 3.79
  • Revenue
  • HROW $227,661,000.00
  • LKFN $248,271,000.00
  • Revenue This Year
  • HROW $43.92
  • LKFN $17.19
  • Revenue Next Year
  • HROW $41.22
  • LKFN $4.34
  • P/E Ratio
  • HROW N/A
  • LKFN $15.15
  • Revenue Growth
  • HROW 47.69
  • LKFN 2.85
  • 52 Week Low
  • HROW $20.85
  • LKFN $50.00
  • 52 Week High
  • HROW $54.19
  • LKFN $78.61
  • Technical
  • Relative Strength Index (RSI)
  • HROW 31.53
  • LKFN 39.02
  • Support Level
  • HROW $36.20
  • LKFN $56.05
  • Resistance Level
  • HROW $38.52
  • LKFN $58.71
  • Average True Range (ATR)
  • HROW 1.65
  • LKFN 1.74
  • MACD
  • HROW -0.43
  • LKFN -0.02
  • Stochastic Oscillator
  • HROW 10.74
  • LKFN 23.37

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

About LKFN Lakeland Financial Corporation

Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. It offers a broad line of products and services throughout its Northern and Central Indiana markets. The company provides commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare.

Share on Social Networks: